NNHF Unveiled at ASH2025: Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
Amos Gitonga M, Associate Programme Manager-Southern Africa at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
“While some of our Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) colleagues unveiled at ASH2025 in Orlando, we celebrated an inspiring Africa Unveil in Nairobi, Kenya NNHF Africa Unveil.
Together with partners from across Africa, we marked a bold new chapter: expanding beyond haemophilia care to include sickle cell disease (SCD) and thalassemia.
After two decades of impact, this is a new horizon and a momentum we are excited to carry forward. I look forward to working with incredible partners in Africa to strengthen care where it is most needed.
Our shared goal: to build an integrated model of care for haemophilia and SCD, while also advancing tailored approaches for each condition as needed. By leveraging shared resources, we aim to strengthen service delivery and improve access, and outcomes for people living with these conditions.”
Read more about ASH2025 on Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis